首页> 外文期刊>Prostate International >Optimizing prophylactic antibiotic regimen in patients admitted for?transrectal ultrasound-guided prostate biopsies: A prospective randomized study
【24h】

Optimizing prophylactic antibiotic regimen in patients admitted for?transrectal ultrasound-guided prostate biopsies: A prospective randomized study

机译:经直肠超声引导的前列腺活检入院患者的最佳预防性抗生素治疗方案:一项前瞻性随机研究

获取原文
           

摘要

Background Transrectal ultrasound-guided prostate biopsies (TRUSBx), in spite of being one of the most frequently performed urological office procedures, are associated with a spectrum of complications, most significantly including infection. The aim of the study is to evaluate the prevalence of fluoroquinolone-resistant bacteria in rectal swabs from our local population prior to TRUSBx and to identify risk factors among a patient population harboring fluoroquinolone-resistant organisms. Methods We prospectively included 541 men who were submitted for TRUSBx in our center from March 2011 to June 2015. The indications for TRUSBx were an elevated prostate-specific antigen level and/or abnormal digital rectal exam. All patients were randomly divided into two groups: Group 1 ( n ?=?279 cases) who received standard empirical prophylactic antibiotics and Group 2 who received targeted prophylaxis based on a rectal swab culture and susceptibility result. Differences in risk factors between quinolone-resistant and nonresistant patients were compared. Univariate and multivariate analyses were performed to identify independent potential risk factors associated with fluoroquinolone-resistant rectal flora. Results Sixteen out of 271 men developed infectious complications after TRUSBx in the group receiving standard empirical prophylaxis (5.7%). No men in the group who received targeted prophylactic antibiotic guided by rectal swab developed infectious complications. Among the 262 patients who underwent prebiopsy rectal swab cultures, 76 men (29%) displayed fluoroquinolone-resistant rectal flora (29%). In the multivariate analysis, a history of antibiotic exposure before prostate biopsy was the only independent factor associated with an increased risk of fluoroquinolone resistance. Conclusion Determining the prevalence of fluoroquinolone resistance in rectal flora has important implications in the selection of targeted prophylactic antibiotic regimens. Antimicrobial profiles guided by rectal swabs may prove useful to optimize prophylaxis prior to TRUSBx; this strategy is effective at reducing the rates of infectious complications, including sepsis, especially in men at higher risk of infectious complications.
机译:背景尽管经直肠超声引导的前列腺活检(TRUSBx)是最常进行的泌尿科诊治程序之一,但仍与一系列并发症有关,其中最明显的是感染。这项研究的目的是评估在TRUSBx之前来自我们当地人群的直肠拭子中对氟喹诺酮耐药的细菌的流行,并确定具有耐氟喹诺酮生物的患者人群中的危险因素。方法我们从2011年3月至2015年6月在我们中心收治的541例男性接受了TRUSBx治疗。TRUSBx的适应症包括前列腺特异性抗原水平升高和/或直肠指检异常。所有患者随机分为两组:第1组(n = 279例)接受标准的经验性预防性抗生素治疗;第2组根据直肠拭子培养和药敏结果接受有针对性的预防。比较了喹诺酮耐药和非耐药患者的危险因素差异。进行单因素和多因素分析,以确定与氟喹诺酮耐药的直肠菌群相关的独立潜在危险因素。结果在接受标准的经验性预防的该组271名男性中,有16名发生了TRUSBx术后感染性并发症(5.7%)。在该组中,没有任何人接受了由直肠拭子引导的靶向预防性抗生素的感染性并发症。在262名接受活检前直肠拭子培养的患者中,有76名男性(29%)表现出对氟喹诺酮耐药的直肠菌群(29%)。在多变量分析中,前列腺穿刺前的抗生素暴露史是与氟喹诺酮耐药风险增加相关的唯一独立因素。结论确定直肠菌群中氟喹诺酮耐药的发生率对选择靶向预防性抗生素方案具有重要意义。直肠拭子引导的抗菌谱可能被证明有助于优化TRUSBx之前的预防措施。此策略可有效降低包括败血症在内的感染并发症的发生率,尤其是在感染并发症风险较高的男性中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号